Abstract

ObjectivesTo assess the nationwide seasonal peaks, risk factors, and utilization of medical resources of respiratory syncytial virus-associated hospitalization (RSVH) in preterm infants in Taiwan.Study designA Taiwan nationwide birth cohort was extracted from the Birth Certificate Application Database during 2007–2009 and prospectively linked to the National Health Insurance database. We evaluated the seasonal peaks and risk factors (gestational age [GA], chronologic age [CA], and bronchopulmonary dysplasia [BPD]) associated with the RSVH of preterm infants. The length of hospital stays (LOS), care in intensive care unit (ICU), and use of mechanical ventilation (MV) were also analyzed.ResultsThere is a total duration of 9 months of RSVH season in Taiwan, three seasonal peaks and two seasonal peaks of RSVH in preterm infants with BPD and without BPD, respectively. Preterm infants had significantly higher RSVH rate than term infants (2.6% vs 0.9%, p<0.0001). Preterm infants born at 29–35 weeks of gestational age (wGA) with BPD had significantly higher RSVH rate than those without BPD (p<0.0001). Preterm infants without BPD born at < 32 wGA had higher RSVH rate than those born at 33–35 wGA (p<0.0001). Overall, 56.4% of RSVH occurred within 9 months of CA. Preterm infants with BPD had significantly higher ICU admission rate within 18 months of CA (p<0.0001), MV usage within 12 months of CA (p<0.0001) and LOS within 18 months of CA (p<0.001) than those without BPD. RSVH occurred within 6 months of CA was significantly associated with higher ICU admission rate (p<0.0001), MV usage (p = 0.0002) and longer LOS (p<0.001) in preterm infants without BPD.ConclusionsThere is a total duration of 9 months of RSVH season in Taiwan. Preterm < 32 wGA, BPD, and CA within 6 months were risk factors of RSVH which also contribute to higher utilization of medical resources.

Highlights

  • Respiratory syncytial virus (RSV) is an important virus for lower respiratory tract infections among infants and young children [1,2]

  • Preterm < 32 weeks of gestational age (wGA), bronchopulmonary dysplasia (BPD), and Chronologic age (CA) within 6 months were risk factors of RSV-associated hospitalization (RSVH) which contribute to higher utilization of medical resources

  • There is a total duration of 9 months of RSVH season of preterm infants

Read more

Summary

Introduction

Respiratory syncytial virus (RSV) is an important virus for lower respiratory tract infections among infants and young children [1,2]. Populations at risk for RSV-associated hospitalization (RSVH) include infants who are born before 35 weeks of gestational age (wGA), with bronchopulmonary dysplasia (BPD), and who have hemodynamically significant congenital heart disease (HS-CHD) [5]. Since 1998, the American Academy of Pediatrics (AAP) has recommended palivizumab prophylaxis guidelines against RSV according to their BPD status, gestational age(GA) and CA at the beginning of the RSV season to prevent the respiratory complication [7]. Because of the high costs of RSV prophylaxis [8] and additional data regarding seasonality of RSV infection, AAP revised its policy and restricted the palivizumab prophylaxis to preterm infants who were born before 32 wGA and infants born at 32 to 35 wGA with certain risks in 2009 [9]. In 2014, the AAP further evolved palivizumab prophylaxis to preterm infants born before 29 wGA, born at

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call